-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Management of Limited Stage Hodgkin Lymphoma

Program: Education Program
Session: How is the Management Paradigm Evolving for Hodgkin Lymphoma in 2023?
Hematology Disease Topics & Pathways:
Hodgkin lymphoma, Lymphomas, Combination therapy, Diseases, Lymphoid Malignancies
Saturday, December 9, 2023, 4:00 PM-5:15 PM

Sairah Ahmed, MD

Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX

Disclosures: Ahmed: ADC Therapeutics: Consultancy; Servier: Consultancy; Kite/Gilead: Consultancy; Chimagen: Research Funding; Genmab: Research Funding; Merck: Research Funding; Janssen: Research Funding.

See more of: How is the Management Paradigm Evolving for Hodgkin Lymphoma in 2023?
See more of: Education Program
<< Previous Presentation | Next Presentation >>